Business Context and Reporting Period
Company: Topspin Medical, Inc. (Note: Input metadata referenced "My Size, Inc.", but the filing text identifies the registrant as Topspin Medical, Inc.)
Reporting Period: Quarter and nine months ended September 30, 2009.
Status: Development Stage Company. The Company suspended operational activities in October 2008 due to financial constraints and a settlement with bondholders. It has generated no revenue since inception. The Company is currently seeking financing to resume operations or pursue new business opportunities.
Key Financial Metrics (Nine Months Ended Sept 30, 2009)
| Metric | Value (NIS '000s) | Value (USD Approx.) |
|---|---|---|
| Revenue | 0 | $0 |
| Net Loss | (1,803) | ($470,000) |
| Operating Loss | (2,061) | ($540,000) |
| Cash Flow from Operations | (3,081) | ($810,000) |
| Cash and Equivalents (End of Period) | 1,704 | $453,000 |
| Accumulated Deficit | (182,244) | ($48.0M) |
| Current Liabilities | 3,372 | $890,000 |
| Long-Term Liabilities | 3 | $1,000 |
Note: USD conversions are approximate based on rates implied in the text (e.g., NIS 1,704,000 ~ $453,000 implies ~3.76 NIS/USD).
Material Changes vs. Prior Period
- Operational Suspension: R&D and Selling/Marketing expenses dropped to zero for the nine months ended Sept 30, 2009, compared to NIS 14,213,000 and NIS 562,000 respectively in the same period in 2008. This reflects the suspension of operations in October 2008.
- General & Administrative (G&A): G&A expenses decreased significantly to NIS 2,061,000 (9M 2009) from NIS 6,398,000 (9M 2008) due to reduced staffing and operational scale.
- Financing Income: Net financing income was NIS 258,000 (9M 2009) compared to NIS 4,807,000 (9M 2008). The 2008 figure was heavily influenced by fair value changes in debentures and warrants.
- Cash Position: Cash decreased from NIS 3,385,000 (Dec 31, 2008) to NIS 1,704,000 (Sept 30, 2009).
Outlook, Risks, and Contingencies
- Going Concern: The filing explicitly states substantial doubt about the Company's ability to continue as a going concern. It has no revenue and requires additional funding to meet obligations and continue operations.
- Failed Acquisition: An acquisition agreement with Anavid Insulation Products (KAST) entered in June 2009 was terminated in October 2009. The Company disputes the claim of fundamental breach made by the counterparty.
- Tax Liability: A tax provision of approximately NIS 1,328,000 ($353,000) exists related to the conversion of Series A Bonds in 2008.
- Government Grants: The Company applied for NIS 3,200,000 in grants from the Office of the Chief Scientist for 2008 expenses, but receipt is uncertain.
- Management Changes: Subsequent to the period end (Nov 15, 2009), the Chairman of the Board, Mr. Ehud-Moshe Gilboa, resigned. Mr. Zvi Lindowski was appointed as a new director.
Investor Verification Checklist
- Cash Runway: Verify if the current cash balance (NIS 1.7M) is sufficient to cover the NIS 1.3M tax liability and ongoing G&A expenses without immediate fundraising.
- Fundraising Status: Confirm the status of negotiations with potential investors mentioned in the "Liquidity and Capital Resources" section.
- Legal Dispute: Assess the potential financial impact of the dispute regarding the terminated acquisition agreement with Anavid/KAST.
- Grant Approval: Determine if the NIS 3.2M grant application from the Office of the Chief Scientist has been approved or rejected.
- Shareholder Structure: Review the impact of the resignation of the Chairman and the appointment of a new director on future strategic direction.